Dublin, April 03, 2018 (GLOBE NEWSWIRE) -- The "Global Diagnostic Imaging Partnering Terms and Agreements 2012 to 2018" report has been added to ResearchAndMarkets.com's offering.

The Global Diagnostic Imaging Partnering Terms and Agreements 2012 to 2018 report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

This report provides a comprehensive and detailed review of all diagnostic imaging deals announced since 2012. The comprehensive agreements chapter is organized by company A-Z, stage of development at signing, deal type, and therapy focus. Each deal title links via Weblink to an online version of the actual deal at Current Agreements ([external URL] deals and alliances database, providing easy access to each deal on demand. Where available, the full deal contract document is also provided and indicated by a document symbol.

Contract documents provide unsurpassed access to the detail of a deal normally announced in brief summary through a press release. Detailed analysis of a contract allow better understanding of the terms agreed between the parties, and importantly the basis under which monies and licensing rights are exchanged.

In addition, a comprehensive appendix is provided organized by Diagnostic Imaging partnering company A-Z, deal type definitions and Diagnostic Imaging partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Diagnostic Imaging technologies and products.

Report scope

Global Diagnostic Imaging Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding of the diagnostic imaging trends and structure of deals entered into by leading companies worldwide.

Global Diagnostic Imaging Partnering Terms and Agreements includes:

• Trends in diagnostic imaging dealmaking in the biopharma industry since 2012
• Analysis of diagnostic imaging deal structure
• Case studies of real-life diagnostic imaging deals
• Access to over 900 diagnostic imaging contract documents
• The leading diagnostic imaging deals by value since 2012
• Most active diagnostic imaging dealmakers since 2012
• The leading diagnostic imaging partnering resources

In Global Diagnostic Imaging Partnering Terms and Agreements, the available contracts are listed by:

• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Specific technology target

Each deal title links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The Global Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive access to available contract documents for over 900 diagnostic imaging deals. Analyzing actual contract agreements allows assessment of the following:

• What are the precise diagnostic rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering:

• Imaging
• CT
• Endoscope
• Molecular and nuclear
• PET
• SPECT
• MRI
• Ultrasound
• X ray
• Angiography
• Fluoroscopy
• Mammography

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Diagnostic Imaging dealmaking

2.1. Introduction
2.2. Diagnostic Imaging partnering over the years
2.3. Most active Diagnostic Imaging dealmakers
2.4. Diagnostic Imaging partnering by deal type
2.5. Diagnostic Imaging partnering by therapy area
2.6. Deal terms for Diagnostic Imaging partnering
2.6.1 Diagnostic Imaging partnering headline values
2.6.2 Diagnostic Imaging deal upfront payments
2.6.3 Diagnostic Imaging deal milestone payments
2.6.4 Diagnostic Imaging royalty rates

Chapter 3 - Leading Diagnostic Imaging deals

3.1. Introduction
3.2. Top Diagnostic Imaging deals by value

Chapter 4 - Most active Diagnostic Imaging dealmakers

4.1. Introduction
4.2. Most active Diagnostic Imaging dealmakers
4.3. Most active Diagnostic Imaging partnering company profiles

Chapter 5 - Diagnostic Imaging contracts dealmaking directory

5.1. Introduction
5.2. Diagnostic Imaging contracts dealmaking directory

Chapter 6 - Diagnostic Imaging dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Diagnostic Imaging deals by company A-Z
Appendix 2 - Diagnostic Imaging deals by stage of development
Appendix 3 - Diagnostic Imaging deals by deal type
Appendix 4 - Diagnostic Imaging deals by therapy area
Appendix 5 - Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/research/brdqn3/global_diagnostic?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Medical Imaging